Major Scope

  •  Colon and Rectal Surgery
  •  General Surgery
  •  Gynecologic Oncology
  •  Plastic Surgery
  •  Neurological Surgery
  •  Orthopaedic Surgery
  •  Orthopaedic Surgery of the Spine
  •  Neonatal Surgery
  •  Prenatal Surgery
  •  Trauma Surgery
  •  Surgical Intensivists, Specializing In Critical Care Patients
  •  Thoracic Surgery
  •  Congenital Cardiac Surgery
  •  Thoracic Surgery-Integrated
  •  Vascular Surgery

Abstract

Citation: Clin Surg. 2019;4(1):2359.Case Report | Open Access

Esophageal Cancer Showing Complete Remission of Nephrotic Syndrome after Neoadjuvant Chemotherapy Plus Surgery

Chao Cheng, Weixiong Yang, Shuishen Zhang and Sai-Ching Jim Yeung

Department of Thoracic Surgery, The First Affiliated Hospital of Sun Yat-sen University, China
Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, USA

*Correspondance to: Chao Cheng 

 PDF  Full Text DOI: 10.25107/2474-1647.2359

Abstract

How to treat esophageal cancer with concurrent nephrotic syndrome is major challenge. We report a patient treated with neoadjuvant chemotherapy plus surgical resection of esophageal cancer, resulting in a complete remission of NS. The patient achieved partial response and down staged from cT2N1M0 to cT1bN0M0 after neoadjuvant chemotherapy (nedaplatin and liposomal paclitaxel). Using intravenous albumin to maintain serum albumin >30 g/L, esophagectomy via video-assisted Mckewon approach was performed with no major perioperative complications. There was no recurrence of cancer or relapse of NS at 32 months after surgery. We concluded that neoadjuvant chemotherapy plus esophagectomy with Mckewon approach seems to be safe and effective for esophageal cancer patient with NS, maintaining serum albumin >30 g/L may mitigate concerns of surgical complications.

Keywords

Esophageal cancer; Nephrotic syndrome; Neoadjuvant chemotherapy; Surgery

Cite the article

Cheng C, Yang W, Zhang S, Jim Yeung S-C. Esophageal Cancer Showing Complete Remission of Nephrotic Syndrome after Neoadjuvant Chemotherapy Plus Surgery. Clin Surg. 2019; 4: 2359.

Journal Basic Info

  • Impact Factor: 2.395**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
  • NLM ID: 101702548

Search Our Journal

Journal Indexed In

Articles in PubMed

Mesh Sprayer Device with Liquefied Mesh Delivery System: Proposed Alternative for Currently Available Meshes in Hernia Repair and Supplement to Abdominal Closure
 PubMed  PMC  PDF  Full Text
RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Study on Risk Factors and Prognosis of Lymph Node Metastasis of Siewert II/III Adenocarcinoma of Esophagogastric Junction
 Abstract  PDF  Full Text
Subpedicle Subtraction Osteotomy for Treatment of Posttraumatic Thoracolumbar Kyphosis
 Abstract  PDF  Full Text
View More...